This technology, exclusively licensed from CHOP, focuses on modifying gene therapy vectors, incorporating companion therapies ...

reverse plummeting childhood vaccination rates’ fueling measles resurgences in 32 states and address climate-driven disease vectors creeping northward — all while navigating a political ...